Lupin Pharmaceuticals Inc. recalls Cefdinir for Oral Suspension USP, 250 mg/5mL, packaged in 60 mL bottles, Rx only, Manufactured for: Lupin Pharmaceutical
Recalled July 29, 2020 · FDA recall D-1406-2020 · Lupin Pharmaceuticals
Hazard
Superpotent Drug: Out-of-specification (OOS) result observed in an assay test of retention samples. · FDA Class II
Units
35,928 bottles
Sold at
U.S.A. Nationwide
Description
Superpotent Drug: Out-of-specification (OOS) result observed in an assay test of retention samples.
Product
Cefdinir for Oral Suspension USP, 250 mg/5mL, packaged in 60 mL bottles, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland, Manufactured by: Lupin Limited, Mandideep, India, NDC 68180-723-20
Manufacturer(s)
Lupin Pharmaceuticals Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →